0

“Buzz on the Street” Show: Q BioMed (OTCQB: QBIO) Mannin Research Reports Data: Acute Kidney Injury

Q BioMed Inc. (OTCQB: QBIO), a commercial stage biotech company, is announcing today that its technology research partner Mannin Research Inc. (Mannin) presented positive data on a potential new treatment for acute kidney injury (AKI). The data was presented at the American Society for Nephrology 2019 Annual Meeting held in Washington DC. Q BioMed Inc. […]

0

“Buzz on the Street” Show: Q BioMed Inc. (OTCQB: QBIO) Announces FDA Approval

Q BioMed Inc. (OTCQB: QBIO), announces FDA approval of its contract manufacturer IsoTherapeutics Group LLC (ITG). ITG is now cleared to manufacture the Company’s FDA approved non-opioid cancer bone pain drug Strontium-89 Chloride USP. Q BioMed Inc. is a biotech acceleration and commercial stage company. We are focused on licensing and acquiring undervalued biomedical assets […]

0

“Buzz on the Street” Show: Q BioMed Inc. (OTCQB: QBIO) Partner Mannin Announces USD 7.5M Grant

Q BioMed Inc. (OTCQB: QBIO), a commercial stage biotech company, announced today that its technology partner, Mannin, has received a $7.5M grant from the German state of Saxony. Mannin is a research-stage biotechnology company focused on the discovery, development, and commercialization of therapeutics for vascular diseases. It was founded in July 2012 and is led […]

0

“Buzz on the Street” Show: UMG Media Ltd. (TSX-V: ESPT) Letter of Intent by Torque Esports Corp.

Torque Esports Corp., formerly Millennial Esports Corp. (TSXV: GAME) (OTCQB: MLLLF) and UMG Media Ltd. (TSX-V: ESPT) have entered into a binding letter of intent (the “Letter of Intent”) dated October 21, 2019 whereby Torque will acquire UMG (the “Transaction”), which is an arm’s length transaction. The Transaction combines two highly complementary businesses in the […]

0

“Behind the Buzz” Show: Interlapse Technologies (TSX-V: INLA) CEO & Director Wayne Chen

Interlapse Technologies Corp. (TSX-V: INLA) (OTCQB: INLAF) is a Canadian based FinTech company focused on developing the next generation of applications for virtual currency. Our coincurve.com platform, with payment and financial infrastructure, accelerates the global mega trend of virtual currency adoption and the transformation of money. Wayne Chen is an early adopter and investor in […]

0

“Behind the Buzz” Show: Nutritional High International (CSE: EAT) Co-Chair & Director David Posner

Nutritional High International Inc. (CSE: EAT) (OTCQB: SPLIF) is focused on developing, manufacturing and distributing products under recognized brands in the cannabis products industry, with a specific focus on edibles and oil extracts for medical and adult recreational use. The Company works exclusively with licensed facilities in jurisdictions where such activity is permitted and regulated […]

0

“Behind the Buzz” Show: Nexleaf Solutions (CSE: OILS) (OTCQB: OILFF) CEO Paul Pedersen

Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) pioneers the development and delivery of market-validated, patented cannabis processing solutions. The company maximizes the return on every harvest, through innovative processes and value-added products. Nextleaf’s vision is to set the global standard for the development of novel extraction technology. The Company provides processing solutions for the next […]

0

“Buzz on the Street” Show: Pressure Biosciences (OTCQB: PBIO) Coverage By Zacks Small Cap Research

Pressure BioSciences, Inc. (OTCQB: PBIO) announced that Zacks Small Cap Research (“Zacks SCR”) has initiated coverage on the Company. Pressure BioSciences, Inc. is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences industry. Our primary focus is in the development of PCT-based products for biomarker and […]

0

“Buzz on the Street” Show: Q BioMed Inc. (OTCQB: QBIO) Partnership with Jubilant Radiopharma

Q BioMed Inc. (OTCQB: QBIO), a commercial stage biotech company, announced today it has entered into an exclusive distribution agreement for its non-opioid metastatic cancer pallion drug, Strontium-89 Chloride Injection USP (Strontium-89)/Metastron™, with Jubilant Radiopharma for the United States market. Jubilant Radiopharma is an industry leading pharmaceutical company specializing in nuclear medicine focused on developing, […]

0

“Buzz on the Street” Show: Pressure Biosciences (OTCQB: PBIO) Presents at Gynecologic Cancer Meeting

Pressure BioSciences, Inc. (OTCQB: PBIO) announced the Company’s patented pressure cycling technology (“PCT”) platform was featured as an integral part of a new, innovative workflow for the analysis of proteins from cancer biopsy samples. This workflow was presented in a plenary session at the Annual Meeting of the International Gynecologic Cancer Society (“IGCS”) on September […]